Friday, 21 Feb 2020

Biologic/Novel Rx

Datesort ascending Type Title Save
12 Jul 2018 Social RT @ByJonGardner: Some interesting insight on why US biosimilar uptake has been so anaemic from a Leerink note. Main reasons: PBMS lose mon…
12 Jul 2018 News Defining Refractory RA by Biologic Use
11 Jul 2018 News IL-23 Inhibitor Fails in Ankylosing Spondylitis
10 Jul 2018 Blog Prescription Drugs and the Effect on Access to Biosimilars in the US
09 Jul 2018 Social RT @SGottliebFDA: For this week’s #FDA #SUNDAYTWEETORIAL, I want to talk about #biosimilars. It's a critical moment in the development of t…
26 Jun 2018 News Five Barriers to Biosimilar Adoption in the US
25 Jun 2018 Social RheumNow Week in Review is up! Cush reviews lack of DMOADs, EULAR18, Penicillamine cost, ANCA+ Infections , NSAIDs in Pregnancy and Seropostive vs. Seronegative Outcomes. or do the podcast on iTunes or here>>
25 Jun 2018 Social Uncontrolled, off-label reports of Tofacitinib 10 mg bid in patients with refractory dermatomyositis - promising but more clinical trial data needed!
20 Jun 2018 ACR Video Dr. Olga Petryna at EULAR 2018 - Biologics Don't Effect Infection Rates with Arthroplasty
18 Jun 2018 News EULAR 2018 - Day 4 Report
15 Jun 2018 News High Biologic Blood Levels Increases the Risk of Infections in RA
15 Jun 2018 ACR Video Dr. Olga Petryna at EULAR 2018 - Biologics Don't Affect Infection with Arthroplasty
15 Jun 2018 Social RT @CreakyJoints: US physicians are more prone to continue biologics through pregnancy. Per a research poster presented at #EULAR2018 https…
15 Jun 2018 ACR Video Dr. Artie Kavanaugh at EULAR 2018 - Biosimilar Switching Studies
14 Jun 2018 Social RT @jomargwhite: MTX associated with reduction of CVD risk in patients reviving biologic treatment #eular2018 #methotrexate…
14 Jun 2018 Social RT @RajkiranDudam: Do s and Dont's before think of switching to biosimilars #EULAR2018
14 Jun 2018 Social RT @DrJuanOvalles: Promising results with folistatin gene therapy for sporadic inclusion body Myositis. A significant improvement of functi…
14 Jun 2018 News Biosimilar Data at #EULAR2018
14 Jun 2018 News Abbvie Highlights Upadacitinib Trials at EULAR18
13 Jun 2018 Social RT @philipcrobinson: A phase IIB study of UCBs new anti-IL-17 drug bimekizumab that neutralises both IL17 A and F showed good results, can’…